Aleksandr Rabodzey

Aleksandr Rabodzey is Managing Director at Suvretta Capital Management, LLC, based in Menlo Park, California. In this senior investment role, he is responsible for leading investment research, portfolio strategy, and capital allocation, with an emphasis on generating alpha across public equities.

Rabodzey has a strong career background in equity research and hedge fund management, having previously served as Analyst-Equity at PFM Health Sciences LP and Sanford C. Bernstein & Co. LLC, where he specialized in public markets investing with a focus on the healthcare, biotechnology, and pharmaceutical sectors. He also held corporate officer and consulting positions at Syneos Health Consulting and Rosetta Ltd, supporting strategic and operational initiatives for clients in the life sciences and finance industries.

He holds an undergraduate degree from the Moscow Institute of Physics & Technology and a doctorate from the Massachusetts Institute of Technology (MIT), establishing his expertise in quantitative analysis and scientific disciplines. Rabodzey is recognized for his analytical rigor and sector experience, particularly in healthcare and alternative asset management, and has contributed to investment and risk management practices across multiple leading organizations.